Antimicrobial Peptide Synergies for Fighting Infectious Diseases.

Jessica T Mhlongo, Ayman Y Waddad, Fernando Albericio, Beatriz G de la Torre
Author Information
  1. Jessica T Mhlongo: KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa.
  2. Ayman Y Waddad: Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Westville, Durban, 4000, South Africa.
  3. Fernando Albericio: Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Westville, Durban, 4000, South Africa. ORCID
  4. Beatriz G de la Torre: KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa.

Abstract

Antimicrobial peptides (AMPs) are essential elements of thehost defense system. Characterized by heterogenous structures and broad-spectrumaction, they are promising candidates for combating multidrug resistance. Thecombined use of AMPs with other antimicrobial agents provides a new arsenal ofdrugs with synergistic action, thereby overcoming the drawback of monotherapiesduring infections. AMPs kill microbes via pore formation, thus inhibitingintracellular functions. This mechanism of action by AMPs is an advantage overantibiotics as it hinders the development of drug resistance. The synergisticeffect of AMPs will allow the repurposing of conventional antimicrobials andenhance their clinical outcomes, reduce toxicity, and, most significantly,prevent the development of resistance. In this review, various synergies ofAMPs with antimicrobials and miscellaneous agents are discussed. The effect ofstructural diversity and chemical modification on AMP properties is firstaddressed and then different combinations that can lead to synergistic action,whether this combination is between AMPs and antimicrobials, or AMPs andmiscellaneous compounds, are attended. This review can serve as guidance whenredesigning and repurposing the use of AMPs in combination with other antimicrobialagents for enhanced clinical outcomes.

Keywords

References

  1. Eur J Pharmacol. 1992 Aug 3;226(4):287-96 [PMID: 1383011]
  2. Adv Pharm Bull. 2021 Sep;11(4):693-699 [PMID: 34888216]
  3. Nucleic Acids Res. 2004 Jan 1;32(Database issue):D590-2 [PMID: 14681488]
  4. FEBS Lett. 2009 Aug 6;583(15):2507-12 [PMID: 19589339]
  5. Future Med Chem. 2016 Jun;8(10):1035-45 [PMID: 27285299]
  6. Infect Dis Ther. 2021 Mar;10(1):115-147 [PMID: 33523419]
  7. Proc Natl Acad Sci U S A. 2010 May 18;107(20):9352-7 [PMID: 20435915]
  8. Front Med Technol. 2020 Dec 21;2:615494 [PMID: 35047895]
  9. Res Microbiol. 2011 Feb-Mar;162(2):99-107 [PMID: 20868743]
  10. Adv Exp Med Biol. 1998;443:229-37 [PMID: 9781363]
  11. PLoS One. 2009 Sep 28;4(9):e7191 [PMID: 19784377]
  12. RSC Adv. 2019 Mar 5;9(13):7239-7245 [PMID: 35519960]
  13. FEMS Microbiol Lett. 1998 Mar 1;160(1):91-6 [PMID: 9495018]
  14. Infect Immun. 1984 Jul;45(1):150-4 [PMID: 6735465]
  15. Prog Lipid Res. 2012 Apr;51(2):149-77 [PMID: 22245454]
  16. Front Microbiol. 2020 Feb 14;11:103 [PMID: 32117132]
  17. J Antimicrob Chemother. 2002 Feb;49 Suppl 1:7-10 [PMID: 11801575]
  18. Int J Nanomedicine. 2013;8:4721-31 [PMID: 24376352]
  19. Biosci Rep. 2017 Sep 27;37(5): [PMID: 28894024]
  20. Infect Immun. 1986 Jun;52(3):902-4 [PMID: 3519465]
  21. Antibiotics (Basel). 2020 Jun 23;9(6): [PMID: 32585881]
  22. Biochemistry. 2007 Dec 11;46(49):14284-90 [PMID: 18004888]
  23. PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2267 [PMID: 23785532]
  24. Antimicrob Agents Chemother. 2014 Oct;58(10):5719-25 [PMID: 25022581]
  25. Probiotics Antimicrob Proteins. 2010 Mar;2(1):52-60 [PMID: 20383320]
  26. Trends Pharmacol Sci. 2019 Jul;40(7):517-528 [PMID: 31230616]
  27. Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-74 [PMID: 17346671]
  28. Rev Infect Dis. 1990 Mar-Apr;12(2):308-29 [PMID: 2184499]
  29. J Biol Chem. 2011 Jul 8;286(27):24394-406 [PMID: 21586570]
  30. Adv Exp Med Biol. 2019;1117:3-6 [PMID: 30980349]
  31. J Biosci Bioeng. 2009 May;107(5):475-87 [PMID: 19393544]
  32. Antimicrob Agents Chemother. 2019 Oct 7;63(12): [PMID: 31591129]
  33. Immunology. 2002 May;106(1):20-6 [PMID: 11972628]
  34. J Biol Chem. 1992 Nov 15;267(32):23216-25 [PMID: 1429669]
  35. Biotechnol Lett. 2005 Sep;27(18):1337-47 [PMID: 16215847]
  36. Antimicrob Agents Chemother. 1998 Oct;42(10):2645-9 [PMID: 9756770]
  37. J Immunol. 2002 Oct 1;169(7):3883-91 [PMID: 12244186]
  38. Nature. 2006 Oct 19;443(7113):867-9 [PMID: 17051220]
  39. J Biol Chem. 2005 Mar 11;280(10):9272-82 [PMID: 15546886]
  40. Biofouling. 2019 May;35(5):573-584 [PMID: 31282211]
  41. Biochemistry. 2015 Apr 7;54(13):2262-9 [PMID: 25777778]
  42. BJOG. 2019 Dec;126(13):1546-1552 [PMID: 31446677]
  43. J Antimicrob Chemother. 2006 Jan;57(1):94-103 [PMID: 16291868]
  44. Antimicrob Agents Chemother. 2008 Dec;52(12):4483-5 [PMID: 18794382]
  45. Chem Biol Drug Des. 2006 Sep;68(3):148-53 [PMID: 17062012]
  46. ACS Infect Dis. 2022 Nov 11;8(11):2339-2347 [PMID: 36255133]
  47. Antimicrob Agents Chemother. 2012 Dec;56(12):6366-71 [PMID: 23070152]
  48. Cell Mol Life Sci. 2006 May;63(9):1060-9 [PMID: 16572270]
  49. J Pept Sci. 2017 Mar;23(3):228-235 [PMID: 28120548]
  50. Microb Pathog. 2019 Mar;128:171-177 [PMID: 30610901]
  51. Antimicrob Agents Chemother. 2005 Jan;49(1):269-75 [PMID: 15616305]
  52. Nature. 1981 Jul 16;292(5820):246-8 [PMID: 7019715]
  53. Adv Protein Chem Struct Biol. 2018;112:359-384 [PMID: 29680241]
  54. PLoS One. 2015 Aug 06;10(8):e0132701 [PMID: 26248029]
  55. Antimicrob Agents Chemother. 2001 May;45(5):1337-42 [PMID: 11302792]
  56. Toxicon. 2004 Jul;44(1):67-74 [PMID: 15225564]
  57. Peptides. 2009 Oct;30(10):1794-7 [PMID: 19591887]
  58. Eur J Haematol. 1990 Jan;44(1):1-8 [PMID: 2407547]
  59. Expert Rev Anti Infect Ther. 2022 Feb;20(2):161-178 [PMID: 34128761]
  60. Int J Food Microbiol. 2008 Dec 10;128(2):390-4 [PMID: 18819721]
  61. J Biol Chem. 2006 Sep 29;281(39):28565-74 [PMID: 16867990]
  62. Curr Opin Chem Biol. 2017 Jun;38:87-96 [PMID: 28399505]
  63. Trends Biotechnol. 2013 Mar;31(3):177-84 [PMID: 23333434]
  64. Clin Pharmacokinet. 1993 Jan;24(1):10-27 [PMID: 8448970]
  65. Protein Expr Purif. 2019 Jul;159:10-16 [PMID: 30807850]
  66. Drug Resist Updat. 2016 May;26:43-57 [PMID: 27180309]
  67. Annu Rev Immunol. 1993;11:105-28 [PMID: 8476558]
  68. Biochem Biophys Res Commun. 2015 Nov 27;467(4):967-72 [PMID: 26474700]
  69. Amino Acids. 2012 Oct;43(4):1471-83 [PMID: 22286872]
  70. Biochim Biophys Acta Biomembr. 2020 Jul 1;1862(7):183305 [PMID: 32298679]
  71. Pharmaceuticals (Basel). 2020 Dec 30;14(1): [PMID: 33396681]
  72. J Biol Chem. 2005 Jan 14;280(2):984-90 [PMID: 15513914]
  73. J Antimicrob Chemother. 2005 Aug;56(2):410-2 [PMID: 15983026]
  74. Chem Rev. 2019 Dec 26;119(24):12375-12421 [PMID: 31829013]
  75. Microbiol Immunol. 1996;40(11):821-5 [PMID: 8985937]
  76. Nat Prod Rep. 2013 Jan;30(1):108-60 [PMID: 23165928]
  77. Inflamm Res. 2000 Feb;49(2):73-9 [PMID: 10738945]
  78. Infect Drug Resist. 2019 May 23;12:1371-1380 [PMID: 31213855]
  79. mBio. 2020 May 12;11(3): [PMID: 32398311]
  80. Probiotics Antimicrob Proteins. 2018 Sep;10(3):408-419 [PMID: 29103131]
  81. J Pept Sci. 2015 Dec;21(12):853-61 [PMID: 26470850]
  82. Annu Rev Microbiol. 2002;56:117-37 [PMID: 12142491]
  83. Int J Antimicrob Agents. 2005 Apr;25(4):313-20 [PMID: 15784311]
  84. Drugs. 1995 Jun;49(6):984-1006 [PMID: 7641607]
  85. Biophys J. 1989 Nov;56(5):1017-21 [PMID: 2481510]
  86. J Antimicrob Chemother. 2002 Nov;50(5):731-4 [PMID: 12407132]
  87. Mycoses. 2018 May;61(5):290-297 [PMID: 29377368]
  88. Nat Rev Microbiol. 2005 Nov;3(11):870-81 [PMID: 16261170]
  89. Biochemistry. 1990 May 8;29(18):4490-6 [PMID: 2350550]
  90. Front Microbiol. 2019 Nov 25;10:2719 [PMID: 31824473]
  91. Nat Rev Microbiol. 2006 Jul;4(7):529-36 [PMID: 16778838]
  92. ACS Infect Dis. 2021 Feb 12;7(2):215-253 [PMID: 33433995]
  93. Biophys J. 2013 Mar 19;104(6):L9-11 [PMID: 23528099]
  94. J Immunol. 2000 Jan 15;164(2):549-53 [PMID: 10623792]
  95. Curr Protein Pept Sci. 2012 May;13(3):211-23 [PMID: 22612781]
  96. Pediatr Res. 2003 Apr;53(4):566-72 [PMID: 12612195]
  97. BMC Microbiol. 2016 Jan 27;16:12 [PMID: 26819228]
  98. Antimicrob Agents Chemother. 2020 Sep 21;64(10): [PMID: 32690642]
  99. Biophys J. 2018 Apr 24;114(8):1945-1954 [PMID: 29694871]
  100. Biochemistry. 2002 Apr 2;41(13):4425-36 [PMID: 11914090]
  101. Int J Antimicrob Agents. 2007 Jan;29(1):73-8 [PMID: 17156978]
  102. Drug Discov Today. 2005 Nov 1;10(21):1451-8 [PMID: 16243265]
  103. Comb Chem High Throughput Screen. 2005 May;8(3):241-56 [PMID: 15892626]
  104. Int J Antimicrob Agents. 2005 Mar;25(3):205-10 [PMID: 15737513]
  105. Front Cell Infect Microbiol. 2020 Sep 30;10:526459 [PMID: 33102247]
  106. Angew Chem Int Ed Engl. 2014 Sep 26;53(40):10612-23 [PMID: 25079086]
  107. J Biochem. 1989 Oct;106(4):663-8 [PMID: 2514185]
  108. J Leukoc Biol. 2004 Jan;75(1):39-48 [PMID: 12960280]
  109. Biophys J. 2011 Mar 16;100(6):1473-80 [PMID: 21402029]
  110. Mol Immunol. 2003 Nov;40(7):463-7 [PMID: 14568393]
  111. Expert Opin Biol Ther. 2017 Jun;17(6):663-676 [PMID: 28368216]
  112. J Pept Sci. 2011 May;17(5):306-14 [PMID: 21360627]
  113. Dev Comp Immunol. 2012 Jul;37(3-4):363-70 [PMID: 22327168]
  114. Mycoses. 2014 Apr;57(4):233-9 [PMID: 26058322]
  115. J Am Chem Soc. 2016 Apr 27;138(16):5254-7 [PMID: 27074593]
  116. ACS Infect Dis. 2021 Oct 8;7(10):2826-2835 [PMID: 34514778]
  117. BMC Immunol. 2012 Nov 17;13:61 [PMID: 23157568]
  118. Protein Expr Purif. 2018 Mar;143:28-33 [PMID: 29037914]
  119. J Bacteriol. 1999 Aug;181(16):4848-52 [PMID: 10438754]
  120. Biochim Biophys Acta. 2012 Dec;1820(12):1831-8 [PMID: 22921812]
  121. Sci Rep. 2017 Oct 13;7(1):13153 [PMID: 29030606]
  122. PLoS One. 2013 May 28;8(5):e64010 [PMID: 23724015]
  123. FEBS J. 2013 Dec;280(23):6247-61 [PMID: 24118933]
  124. Antimicrob Agents Chemother. 2014 Jul;58(7):3697-707 [PMID: 24752256]
  125. Crit Rev Microbiol. 2013 May;39(2):180-95 [PMID: 22799636]
  126. Rev Iberoam Micol. 2009 Dec 31;26(4):223-7 [PMID: 19836985]
  127. FEMS Immunol Med Microbiol. 2012 Aug;65(3):399-412 [PMID: 22409572]
  128. J Appl Microbiol. 2014 Sep;117(3):611-7 [PMID: 24863842]
  129. Antonie Van Leeuwenhoek. 2000 Aug;78(2):163-9 [PMID: 11204768]
  130. Eur J Biochem. 1994 Sep 15;224(3):1019-27 [PMID: 7925399]
  131. Antibiotics (Basel). 2019 May 09;8(2): [PMID: 31075940]
  132. Antimicrob Agents Chemother. 1996 Aug;40(8):1801-5 [PMID: 8843284]
  133. Adv Drug Deliv Rev. 2021 Mar;170:261-280 [PMID: 33400958]
  134. Curr Top Med Chem. 2020;20(14):1238-1263 [PMID: 32124698]
  135. Front Microbiol. 2021 Feb 22;12:616979 [PMID: 33692766]
  136. Biophys Chem. 2016 Mar;210:35-44 [PMID: 26099623]
  137. J Mycol Med. 2021 Jun;31(2):101119 [PMID: 33626413]
  138. Nat Commun. 2019 Jun 21;10(1):2730 [PMID: 31227691]
  139. Int J Pharm. 2021 Sep 5;606:120925 [PMID: 34303816]
  140. J Pept Sci. 2005 Nov;11(11):677-87 [PMID: 16103989]
  141. Chem Biol Drug Des. 2008 Dec;72(6):483-95 [PMID: 19090916]
  142. FEBS Lett. 1993 Jan 4;315(2):187-92 [PMID: 8417977]
  143. Eur J Biochem. 1996 Dec 15;242(3):788-92 [PMID: 9022710]
  144. Langmuir. 2018 Sep 18;34(37):11147-11155 [PMID: 30122046]
  145. Phytomedicine. 2018 Feb 1;40:55-58 [PMID: 29496175]
  146. Front Chem. 2018 Jun 05;6:204 [PMID: 29922648]
  147. Front Immunol. 2020 May 07;11:764 [PMID: 32457744]
  148. J Agric Food Chem. 2011 May 25;59(10):5602-8 [PMID: 21469734]
  149. Drugs. 1990 Jun;39(6):877-916 [PMID: 2196167]
  150. FEBS Lett. 2007 Feb 6;581(3):515-20 [PMID: 17250830]
  151. Eur J Biochem. 2000 Mar;267(5):1447-54 [PMID: 10691983]
  152. Nat Chem Biol. 2010 Jan;6(1):9-18 [PMID: 20016494]
  153. Appl Environ Microbiol. 2001 Apr;67(4):1418-22 [PMID: 11282585]
  154. J Exp Med. 2000 Oct 2;192(7):1069-74 [PMID: 11015447]
  155. Sci Rep. 2020 Oct 20;10(1):17745 [PMID: 33082485]
  156. Front Microbiol. 2012 May 21;3:160 [PMID: 22783227]
  157. Biotechnol Adv. 2018 Mar - Apr;36(2):415-429 [PMID: 29330093]
  158. Biophys J. 2019 Nov 19;117(10):1858-1869 [PMID: 31703802]
  159. Clin Exp Immunol. 1980 Apr;40(1):186-92 [PMID: 6993075]
  160. Biochim Biophys Acta. 2015 Nov;1848(11 Pt B):3101-11 [PMID: 25701234]
  161. Eur J Biochem. 1990 Jan 26;187(2):381-6 [PMID: 2298215]
  162. Biochemistry. 2001 Dec 4;40(48):14330-5 [PMID: 11724544]
  163. Mol Microbiol. 2006 Nov;62(3):735-47 [PMID: 17076667]
  164. Biochemistry. 2013 Jun 11;52(23):3987-94 [PMID: 23725536]
  165. Adv Sci (Weinh). 2023 Sep;10(26):e2300472 [PMID: 37407512]
  166. Peptides. 2009 Aug;30(8):1562-74 [PMID: 19465075]
  167. Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406 [PMID: 17158938]
  168. J Biol Chem. 1992 Mar 5;267(7):4292-5 [PMID: 1537821]
  169. Microbiol Spectr. 2016 Apr;4(2): [PMID: 27227291]
  170. Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51 [PMID: 22173434]
  171. Biochemistry. 1992 Dec 22;31(50):12688-94 [PMID: 1472506]
  172. Biochemistry. 2001 Oct 16;40(41):12395-9 [PMID: 11591159]
  173. Med Microbiol Immunol. 2019 Dec;208(6):877-883 [PMID: 31214759]
  174. Antimicrob Agents Chemother. 2005 May;49(5):1727-32 [PMID: 15855488]
  175. Antimicrob Agents Chemother. 1990 Feb;34(2):183-8 [PMID: 2183713]
  176. PLoS One. 2015 Feb 18;10(2):e0117664 [PMID: 25692771]
  177. Int J Antimicrob Agents. 2010 Apr;35(4):347-56 [PMID: 20106636]
  178. Antimicrob Agents Chemother. 2016 Jan 04;60(3):1717-24 [PMID: 26729502]
  179. J Am Chem Soc. 2011 May 25;133(20):7680-3 [PMID: 21526839]
  180. Microb Cell Fact. 2015 Jun 16;14:89 [PMID: 26077560]
  181. J Bacteriol. 1999 Feb;181(3):740-7 [PMID: 9922235]
  182. J Antimicrob Chemother. 2000 Aug;46(2):171-9 [PMID: 10933638]
  183. Int J Microbiol. 2018 Jul 10;2018:8546470 [PMID: 30123275]
  184. Curr Microbiol. 2013 Jan;66(1):56-60 [PMID: 23053486]
  185. Biochemistry. 2000 Nov 21;39(46):14150-9 [PMID: 11087363]
  186. Nat Rev Chem. 2021;5(10):726-749 [PMID: 34426795]
  187. J Virol. 1985 May;54(2):467-72 [PMID: 2985808]
  188. Res Microbiol. 2012 Feb;163(2):101-8 [PMID: 22172555]
  189. Microb Drug Resist. 2015 Aug;21(4):373-9 [PMID: 25785733]
  190. Sci Rep. 2020 Jul 15;10(1):11652 [PMID: 32669585]
  191. J Clin Invest. 1998 Jan 1;101(1):178-87 [PMID: 9421480]
  192. Nat Rev Microbiol. 2005 Mar;3(3):238-50 [PMID: 15703760]
  193. J Biol Chem. 1988 Jun 5;263(16):7472-7 [PMID: 3286634]
  194. Eur Biophys J. 2016 Sep;45(6):535-47 [PMID: 27052218]
  195. Acta Biomater. 2015 Dec;28:99-108 [PMID: 26380930]
  196. Mol Oral Microbiol. 2011 Jun;26(3):187-99 [PMID: 21545696]
  197. Nat Prod Rep. 2000 Aug;17(4):323-35 [PMID: 11014335]
  198. J Acquir Immune Defic Syndr (1988). 1993 Dec;6(12):1311-6 [PMID: 8254467]
  199. J Dermatol Sci. 2005 Nov;40(2):123-32 [PMID: 15963694]
  200. J Immunol. 2007 Mar 1;178(5):3116-25 [PMID: 17312159]
  201. BMJ. 1993 Sep 11;307(6905):645-7 [PMID: 8401048]
  202. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):55-70 [PMID: 10590302]
  203. FEBS Lett. 2017 May;591(10):1349-1359 [PMID: 28391617]
  204. Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):2365-73 [PMID: 26209560]
  205. Biochim Biophys Acta. 2009 Aug;1788(8):1610-9 [PMID: 19422786]
  206. Antimicrob Agents Chemother. 2001 May;45(5):1558-60 [PMID: 11302828]
  207. Langmuir. 2020 Jul 7;36(26):7190-7199 [PMID: 32529830]
  208. J Mol Microbiol Biotechnol. 2007;13(4):210-9 [PMID: 17827971]
  209. Antimicrob Agents Chemother. 1995 Jan;39(1):1-8 [PMID: 7695288]
  210. Antimicrob Agents Chemother. 2015 May;59(5):2508-14 [PMID: 25666157]
  211. J Membr Biol. 2011 Jan;239(1-2):27-34 [PMID: 21225255]
  212. Proc Biol Sci. 2015 May 7;282(1806):20150293 [PMID: 25833860]
  213. Biopolymers. 2017 May;108(3): [PMID: 28073158]
  214. Int J Food Microbiol. 2008 Jul 31;125(3):293-307 [PMID: 18544465]
  215. Microbiology (Reading). 2001 Mar;147(Pt 3):643-651 [PMID: 11238971]
  216. J Pept Sci. 2021 May;27(5):e3306 [PMID: 33554385]
  217. Drugs. 1975;9(6):424-47 [PMID: 1097234]
  218. Front Cell Infect Microbiol. 2016 Dec 27;6:194 [PMID: 28083516]
  219. Microb Pathog. 2020 Feb 9;142:104050 [PMID: 32050093]
  220. Rev Med Interne. 2004 Sep;25(9):629-35 [PMID: 15363618]
  221. J Fungi (Basel). 2020 Nov 27;6(4): [PMID: 33261213]
  222. Peptides. 2007 Aug;28(8):1509-13 [PMID: 17698253]
  223. Front Chem. 2017 Aug 24;5:63 [PMID: 28971093]
  224. Clin Infect Dis. 2008 Jul 1;47(1):123-30 [PMID: 18505387]
  225. Amino Acids. 2006 Jun;30(4):351-67 [PMID: 16622600]
  226. Infect Immun. 2002 Dec;70(12):6524-33 [PMID: 12438321]
  227. PLoS One. 2014 Sep 04;9(9):e106766 [PMID: 25187958]
  228. N Engl J Med. 2002 Oct 10;347(15):1151-60 [PMID: 12374875]
  229. Eur J Biochem. 1995 Mar 1;228(2):257-64 [PMID: 7705337]
  230. Biomolecules. 2018 Apr 18;8(2): [PMID: 29670065]
  231. Cell. 2007 Mar 23;128(6):1037-50 [PMID: 17382878]
  232. J Biosci Bioeng. 2016 May;121(5):591-8 [PMID: 26472128]
  233. Biochem J. 2002 Nov 15;368(Pt 1):91-100 [PMID: 12133008]
  234. Infect Immun. 1985 Jul;49(1):202-6 [PMID: 3891624]
  235. Infect Immun. 1997 Jun;65(6):2389-95 [PMID: 9169779]
  236. J Immunol. 2003 Dec 15;171(12):6690-6 [PMID: 14662872]
  237. Biochemistry. 1998 Oct 27;37(43):15144-53 [PMID: 9790678]
  238. Nature. 2002 Jan 24;415(6870):389-95 [PMID: 11807545]
  239. World J Microbiol Biotechnol. 2014 Dec;30(12):3121-8 [PMID: 25225069]
  240. J Antimicrob Chemother. 2003 Mar;51(3):513-21 [PMID: 12615851]
  241. BMC Cancer. 2018 Apr 26;18(1):467 [PMID: 29695237]
  242. Biomed Res Int. 2014;2014:671362 [PMID: 25003126]
  243. Front Med Technol. 2021 Mar 12;3:640981 [PMID: 35047912]
  244. ACS Infect Dis. 2020 May 8;6(5):761-767 [PMID: 31505930]
  245. Infect Immun. 1999 Jun;67(6):3121-7 [PMID: 10338529]
  246. Biophys J. 2018 Sep 18;115(6):1033-1044 [PMID: 30195937]
  247. Nat Rev Microbiol. 2004 Sep;2(9):727-38 [PMID: 15372083]
  248. Peptides. 2011 Jan;32(1):99-103 [PMID: 21055432]
  249. J Antimicrob Chemother. 2004 Sep;54(3):648-53 [PMID: 15282239]
  250. Sci Rep. 2019 Nov 19;9(1):17029 [PMID: 31745151]
  251. Front Microbiol. 2018 Nov 30;9:2928 [PMID: 30555448]
  252. J Biol Chem. 2006 Oct 27;281(43):32089-94 [PMID: 16877761]
  253. Antimicrob Agents Chemother. 1992 Jun;36(6):1263-71 [PMID: 1416825]
  254. Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):197-204 [PMID: 25169965]
  255. Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):1055-62 [PMID: 23572153]
  256. Front Cell Infect Microbiol. 2021 Jun 14;11:668632 [PMID: 34195099]
  257. Pharmaceuticals (Basel). 2020 Sep 25;13(10): [PMID: 32992877]
  258. Antimicrob Agents Chemother. 2003 Jan;47(1):262-7 [PMID: 12499200]
  259. Antimicrob Agents Chemother. 1998 Jul;42(7):1587-91 [PMID: 9660988]
  260. Mol Microbiol. 2006 Jul;61(2):285-96 [PMID: 16771847]
  261. J Colloid Interface Sci. 2021 Nov;601:517-530 [PMID: 34090029]
  262. Biophys J. 2020 Feb 4;118(3):612-623 [PMID: 31952806]
  263. Fungal Biol. 2014 Feb;118(2):264-75 [PMID: 24528647]
  264. Toxicon. 2010 Nov;56(6):880-9 [PMID: 20600225]
  265. J Pathog. 2018 Dec 27;2018:2068435 [PMID: 30687554]
  266. Sci Rep. 2015 May 12;5:9657 [PMID: 25965506]
  267. Clin Infect Dis. 1994 Oct;19(4):741-5 [PMID: 7803641]
  268. J Glob Antimicrob Resist. 2020 Jun;21:203-210 [PMID: 31678322]
  269. Peptides. 2011 Dec;32(12):2484-7 [PMID: 22015266]
  270. Nat Rev Immunol. 2003 Sep;3(9):710-20 [PMID: 12949495]
  271. J Med Microbiol. 2012 Dec;61(Pt 12):1719-1726 [PMID: 22956753]
  272. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6597-601 [PMID: 2671997]
  273. FEBS J. 2010 Feb;277(4):1010-22 [PMID: 20074208]
  274. Mol Med Rep. 2019 Apr;19(4):3337-3344 [PMID: 30816474]
  275. J Nat Prod. 2016 Apr 22;79(4):1073-83 [PMID: 26998557]
  276. Proc Natl Acad Sci U S A. 1988 Feb;85(3):910-3 [PMID: 3277183]
  277. J Pept Sci. 2015 May;21(5):436-45 [PMID: 25898805]
  278. Biochemistry. 2010 Aug 3;49(30):6462-72 [PMID: 20578714]

MeSH Term

Humans
Anti-Bacterial Agents
Antimicrobial Peptides
Antimicrobial Cationic Peptides
Anti-Infective Agents
Communicable Diseases

Chemicals

Anti-Bacterial Agents
Antimicrobial Peptides
Antimicrobial Cationic Peptides
Anti-Infective Agents

Word Cloud

Created with Highcharts 10.0.0AMPsresistanceactionantimicrobialsAntimicrobialpeptidesuseantimicrobialagentssynergisticdevelopmentrepurposingclinicaloutcomesreviewcancombinationessentialelementsthehostdefensesystemCharacterizedheterogenousstructuresbroad-spectrumactionpromisingcandidatescombatingmultidrugThecombinedprovidesnewarsenalofdrugstherebyovercomingdrawbackmonotherapiesduringinfectionskillmicrobesviaporeformationthusinhibitingintracellularfunctionsmechanismadvantageoverantibioticshindersdrugsynergisticeffectwillallowconventionalandenhancereducetoxicitysignificantlypreventvarioussynergiesofAMPsmiscellaneousdiscussedeffectofstructuraldiversitychemicalmodificationAMPpropertiesfirstaddresseddifferentcombinationsleadwhetherandmiscellaneouscompoundsattendedserveguidancewhenredesigningantimicrobialagentsenhancedPeptideSynergiesFightingInfectiousDiseasesFractionalInhibitoryConcentrationIndexFICIantibioticsmicrobialsynergy

Similar Articles

Cited By